Edition:
United Kingdom

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$1.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
63,109
52-wk High
$5.36
52-wk Low
$0.60

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 17 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 1.00 1.00 1.00 --
Quarter Ending Jun-19 1 1.00 1.00 1.00 --
Year Ending Dec-19 3 12.87 19.60 4.00 56.00
Earnings (per share)
Quarter Ending Mar-19 1 -0.27 -0.27 -0.27 --
Quarter Ending Jun-19 1 -0.27 -0.27 -0.27 --
Year Ending Dec-19 3 -0.89 -0.74 -1.09 -0.71

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.55 0.72 0.17 31.45
Quarter Ending Jun-18 0.90 0.61 0.29 31.89
Quarter Ending Mar-18 8.73 10.48 1.75 20.08
Quarter Ending Dec-17 1.00 0.43 0.57 57.10
Quarter Ending Sep-17 0.30 1.71 1.41 468.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1.00 1.00 1.00 1.00 --
Quarter Ending Jun-19 1.00 1.00 1.00 1.00 --
Year Ending Dec-19 12.87 12.87 12.32 12.32 56.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings